Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000123 | histone acetyltransferase complex | 4 | 7 |
GO:0031248 | protein acetyltransferase complex | 3 | 7 |
GO:0032991 | protein-containing complex | 1 | 7 |
GO:0140535 | intracellular protein-containing complex | 2 | 7 |
GO:1902493 | acetyltransferase complex | 4 | 7 |
GO:1902494 | catalytic complex | 2 | 7 |
GO:1990234 | transferase complex | 3 | 7 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7WZY7
Term | Name | Level | Count |
---|---|---|---|
GO:0006325 | chromatin organization | 4 | 7 |
GO:0006473 | protein acetylation | 6 | 7 |
GO:0006475 | internal protein amino acid acetylation | 7 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016043 | cellular component organization | 3 | 7 |
GO:0016570 | histone modification | 5 | 7 |
GO:0016573 | histone acetylation | 6 | 7 |
GO:0018193 | peptidyl-amino acid modification | 5 | 7 |
GO:0018205 | peptidyl-lysine modification | 6 | 7 |
GO:0018393 | internal peptidyl-lysine acetylation | 8 | 7 |
GO:0018394 | peptidyl-lysine acetylation | 7 | 7 |
GO:0019538 | protein metabolic process | 3 | 7 |
GO:0036211 | protein modification process | 4 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0043412 | macromolecule modification | 4 | 7 |
GO:0043543 | protein acylation | 5 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0071840 | cellular component organization or biogenesis | 2 | 7 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 80 | 84 | PF00656 | 0.561 |
CLV_NRD_NRD_1 | 288 | 290 | PF00675 | 0.640 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.619 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.590 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.608 |
CLV_NRD_NRD_1 | 40 | 42 | PF00675 | 0.342 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.529 |
CLV_PCSK_FUR_1 | 321 | 325 | PF00082 | 0.622 |
CLV_PCSK_KEX2_1 | 261 | 263 | PF00082 | 0.602 |
CLV_PCSK_KEX2_1 | 288 | 290 | PF00082 | 0.651 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.647 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.590 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.632 |
CLV_PCSK_KEX2_1 | 324 | 326 | PF00082 | 0.603 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.340 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.529 |
CLV_PCSK_PC1ET2_1 | 261 | 263 | PF00082 | 0.588 |
CLV_PCSK_PC7_1 | 321 | 327 | PF00082 | 0.691 |
CLV_PCSK_SKI1_1 | 300 | 304 | PF00082 | 0.648 |
DEG_SCF_FBW7_1 | 92 | 98 | PF00400 | 0.568 |
DEG_SPOP_SBC_1 | 241 | 245 | PF00917 | 0.725 |
DOC_CKS1_1 | 92 | 97 | PF01111 | 0.566 |
DOC_MAPK_MEF2A_6 | 46 | 55 | PF00069 | 0.529 |
DOC_PP1_RVXF_1 | 203 | 209 | PF00149 | 0.529 |
DOC_PP2B_LxvP_1 | 126 | 129 | PF13499 | 0.543 |
DOC_PP4_FxxP_1 | 208 | 211 | PF00568 | 0.513 |
DOC_PP4_FxxP_1 | 25 | 28 | PF00568 | 0.543 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.626 |
DOC_USP7_MATH_1 | 176 | 180 | PF00917 | 0.667 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 241 | 245 | PF00917 | 0.624 |
DOC_USP7_UBL2_3 | 257 | 261 | PF12436 | 0.574 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.644 |
DOC_WW_Pin1_4 | 167 | 172 | PF00397 | 0.739 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.548 |
DOC_WW_Pin1_4 | 207 | 212 | PF00397 | 0.535 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.468 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.604 |
LIG_14-3-3_CanoR_1 | 141 | 147 | PF00244 | 0.645 |
LIG_14-3-3_CanoR_1 | 214 | 221 | PF00244 | 0.717 |
LIG_14-3-3_CanoR_1 | 262 | 272 | PF00244 | 0.780 |
LIG_14-3-3_CterR_2 | 324 | 329 | PF00244 | 0.613 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.602 |
LIG_BRCT_BRCA1_1 | 143 | 147 | PF00533 | 0.644 |
LIG_FHA_1 | 137 | 143 | PF00498 | 0.569 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.637 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.468 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.475 |
LIG_MLH1_MIPbox_1 | 143 | 147 | PF16413 | 0.535 |
LIG_SH2_CRK | 140 | 144 | PF00017 | 0.567 |
LIG_SH3_3 | 177 | 183 | PF00018 | 0.664 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.565 |
LIG_SUMO_SIM_par_1 | 88 | 94 | PF11976 | 0.566 |
LIG_TRAF2_1 | 302 | 305 | PF00917 | 0.642 |
LIG_WRC_WIRS_1 | 143 | 148 | PF05994 | 0.535 |
MOD_CDK_SPxxK_3 | 207 | 214 | PF00069 | 0.511 |
MOD_CK1_1 | 121 | 127 | PF00069 | 0.631 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.633 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.602 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.543 |
MOD_CK1_1 | 194 | 200 | PF00069 | 0.705 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.521 |
MOD_CK1_1 | 244 | 250 | PF00069 | 0.770 |
MOD_CK1_1 | 281 | 287 | PF00069 | 0.692 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.514 |
MOD_CK2_1 | 222 | 228 | PF00069 | 0.530 |
MOD_CK2_1 | 234 | 240 | PF00069 | 0.585 |
MOD_Cter_Amidation | 259 | 262 | PF01082 | 0.587 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.580 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.550 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.628 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.618 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.543 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.508 |
MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.772 |
MOD_GlcNHglycan | 276 | 279 | PF01048 | 0.593 |
MOD_GlcNHglycan | 317 | 320 | PF01048 | 0.622 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.477 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.699 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.538 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.579 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.569 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.602 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.689 |
MOD_GSK3_1 | 311 | 318 | PF00069 | 0.578 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.491 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.580 |
MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.640 |
MOD_N-GLC_1 | 315 | 320 | PF02516 | 0.650 |
MOD_NEK2_1 | 234 | 239 | PF00069 | 0.666 |
MOD_NEK2_2 | 185 | 190 | PF00069 | 0.495 |
MOD_PK_1 | 40 | 46 | PF00069 | 0.529 |
MOD_PKA_1 | 40 | 46 | PF00069 | 0.542 |
MOD_PKA_2 | 263 | 269 | PF00069 | 0.637 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.613 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.542 |
MOD_PKB_1 | 262 | 270 | PF00069 | 0.590 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.537 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.522 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.497 |
MOD_Plk_4 | 278 | 284 | PF00069 | 0.491 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.475 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.671 |
MOD_ProDKin_1 | 167 | 173 | PF00069 | 0.739 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.547 |
MOD_ProDKin_1 | 207 | 213 | PF00069 | 0.533 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.461 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.604 |
MOD_SUMO_for_1 | 302 | 305 | PF00179 | 0.642 |
TRG_DiLeu_BaEn_2 | 20 | 26 | PF01217 | 0.580 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.572 |
TRG_ER_diArg_1 | 262 | 265 | PF00400 | 0.579 |
TRG_ER_diArg_1 | 321 | 324 | PF00400 | 0.623 |
TRG_NES_CRM1_1 | 42 | 57 | PF08389 | 0.460 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7C1 | Leptomonas seymouri | 54% | 100% |
A4HF24 | Leishmania braziliensis | 75% | 99% |
E9ACT4 | Leishmania major | 89% | 100% |
E9AHB5 | Leishmania infantum | 99% | 100% |
E9AYF8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |